NasdaqGM - Nasdaq Real Time Price USD

STAAR Surgical Company (STAA)

Compare
32.12 -0.88 (-2.67%)
At close: October 15 at 4:00 PM EDT
Loading Chart for STAA
DELL
  • Previous Close 33.00
  • Open 32.54
  • Bid 32.09 x 100
  • Ask 32.21 x 100
  • Day's Range 31.78 - 32.76
  • 52 Week Range 26.66 - 52.68
  • Volume 571,269
  • Avg. Volume 811,753
  • Market Cap (intraday) 1.58B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 97.33
  • EPS (TTM) 0.33
  • Earnings Date Oct 30, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 49.54

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

www.staar.com

1,056

Full Time Employees

December 29

Fiscal Year Ends

Recent News: STAA

View More

Performance Overview: STAA

Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

STAA
2.92%
S&P 500
21.92%

1-Year Return

STAA
20.51%
S&P 500
34.37%

3-Year Return

STAA
71.92%
S&P 500
31.03%

5-Year Return

STAA
22.83%
S&P 500
96.05%

Compare To: STAA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: STAA

View More

Valuation Measures

Annual
As of 10/14/2024
  • Market Cap

    1.62B

  • Enterprise Value

    1.42B

  • Trailing P/E

    97.33

  • Forward P/E

    625.00

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.77

  • Price/Book (mrq)

    3.86

  • Enterprise Value/Revenue

    4.15

  • Enterprise Value/EBITDA

    43.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.99%

  • Return on Assets (ttm)

    3.66%

  • Return on Equity (ttm)

    4.36%

  • Revenue (ttm)

    332.94M

  • Net Income Avi to Common (ttm)

    16.61M

  • Diluted EPS (ttm)

    0.33

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    235.2M

  • Total Debt/Equity (mrq)

    8.87%

  • Levered Free Cash Flow (ttm)

    22.24M

Research Analysis: STAA

View More

Company Insights: STAA

Research Reports: STAA

View More

People Also Watch